Skip to main content
SpringerLink
Log in

Insulintherapie

  • Chapter
Book cover Diabetes bei Kindern und Jugendlichen

  • 37 Accesses

Zusammenfassung

Eine Diskussion über Indikationen zur Insulintherapie gibt es in der pädiatrischen Diabetologie nicht, denn jedes diabetische Kind und jeder diabetische Jugendliche müssen lebenslang mit Insulin behandelt werden. Diese folgenschwere Tatsache muß, so bitter sie ist, allen Eltern sofort nach Manifestation des Diabetes in schonender, aber eindeutiger Weise dargelegt werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • American Diabetes Association (1988) Position statement on jet injectors. Diabetes Care 11:600

    Google Scholar 

  • Ammon HPT, Schatz H (1995) Verlautbarung der Deutschen Diabetes-Gesellschaft zur subkutanen Insulinapplikation. Diab Stoffw 4: 382

    Google Scholar 

  • Berson SA, Yalow RS (1959) Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest 39: 1996

    Google Scholar 

  • Bertram F (1953) Klinische Beobachtungen über neue verzögernd wirkende Insulinpräparate. Verh Dtsch Ges Inn Med 59:242

    Google Scholar 

  • Brange J, Owens DR, Kang S, Solund A (1990) Monomeric insulins and their experimental and clinical implications. Diabetes Care 13: 923–954

    Google Scholar 

  • Field JB (1973) Extraction of insulin by liver. Am Rev Med 24: 309

    Article  CAS  Google Scholar 

  • Frank BH, Chance RE (1983) Two routes for producing human insulin utilizing recombinant DNA technology. Munch Med Wochenschr 125 (Supp 1)x4

    Google Scholar 

  • Goeddel DV, Kleid DG, Bolivar F et al. (1979) Expression in escherichia coli of chemically synthesized genes for human insulin. Proc Natl Acad Sci (Wash) 76: 106

    Article  CAS  Google Scholar 

  • Hagedorn HC, Jensen NB, Krarup NB, Wodstrup J (1936) Protamine insulinate. Acta Med Scand (Suppl) 78: 678

    Google Scholar 

  • Hallas-Moller K, Petersen K, Schlichtkrull J (1951) Crystalline and amorphous insulin-zinc compounds with prolonged action. Ugeskr Laeger 113: 1761

    PubMed  CAS  Google Scholar 

  • Houtzargers CMGJ, Berntzen PA, Stap H van der, Heine RJ,Veen EA van der (1988) Absorption kinetics of short-and intermediate-acting insulin after jet injection with Medi-Jector II. Diabetes Care 11739

    Google Scholar 

  • Howey DC, Bowsher RR, Brunelle RL, Woodworth JR (1994) (Lys (B28), Pro (1329)-human insulin a rapidly absorbed analogue of human insulin. Diabetes 43: 396–400

    Google Scholar 

  • Johnson IS (1983) Human insulin from recombinant DNA technology. Science 219: 632

    Article  PubMed  CAS  Google Scholar 

  • Krayenbühl C, Rosenberg T (1946) Crystalline protamine-insulin. Rep Steno Mem Hosp (Kbh) 1:60

    Google Scholar 

  • Markussen J (1982) Process for preparing esters of human insulin. US patent 5 343898

    Google Scholar 

  • Obermeier R, Geiger R (1976) A new semisynthesis of human insulin. Hoppe Seylers Z Physiol Chem 357: 759

    Article  PubMed  CAS  Google Scholar 

  • Scott DA, Fisher AM (1935) The effect of zinc salts on the action of insulin. J Pharmacol Exp Ther 55: 206

    Google Scholar 

  • Starke AAR, Heinemann L, Hohmann A, Berger M (1989) The action profiles of human insulin preparations. Diabetic Med 6: 239

    Article  PubMed  CAS  Google Scholar 

  • Thim L, Hansen MZ, Norris K et al. (1986) Secretion and processing of insulin precursors in yeast. Proc Natl Acad Sci USA 83: 6766

    Article  PubMed  CAS  Google Scholar 

  • Vorstand der Deutschen Diabetes-Gesellschaft (1994) Standardisierung der Insulinkonzentration auf loo E/ml am 1.6.1997 in Deutschland, Frankreich and Italien. Diab Stoffw 3:445–446

    Google Scholar 

  • Waldhäusl WK, Gasic S, Bratusch-Marrain P, Nowotny P (1983) The 75-g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man. Diabetologia 25: 489

    Article  PubMed  Google Scholar 

  • Waldhäusl W, Bratusch-Marrain P, Kruse V, Jensen J, Nowotny P, Vierhapper H (1985) Effect of insulin antibodies on insulin pharmacokinetics and glucose utilization in insulin-dependent diabetic patients. Diabetes 34: 166

    Article  PubMed  Google Scholar 

  • Woodworth J, Howey D, Bowsher R, Lutz S, Santa P, Brady P (1993) (Lys (B28), Pro (B29)) human insulin (K): dose ranging vs. Humulin R (H). Diabetes 42 (Suppl 1 ) 54A

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Janusz-Korczak-Allee 12, 30173, Hannover, Deutschland

    Prof. Dr. med. Peter Hürter (apl. Professor an der Medizinischen Hochschule Hannover, Chefarzt am Kinderkrankenhaus auf der Bult)

Authors
  1. Prof. Dr. med. Peter Hürter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hürter, P. (1997). Insulintherapie. In: Diabetes bei Kindern und Jugendlichen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-11466-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-11466-7_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-11467-4

  • Online ISBN: 978-3-662-11466-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation